{{Rsnum
|rsid=17584499
|Gene=PTPRD
|Chromosome=9
|position=8879118
|Orientation=plus
|GMAF=0.1345
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.2 | 34.5 | 5.3
| HCB | 78.8 | 21.2 | 0.0
| JPT | 71.7 | 25.7 | 2.7
| YRI | 93.9 | 6.1 | 0.0
| ASW | 93.0 | 7.0 | 0.0
| CHB | 78.8 | 21.2 | 0.0
| CHD | 91.7 | 8.3 | 0.0
| GIH | 55.4 | 39.6 | 5.0
| LWK | 87.3 | 12.7 | 0.0
| MEX | 55.2 | 37.9 | 6.9
| MKK | 71.2 | 27.6 | 1.3
| TSI | 55.4 | 42.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20174558
|Trait=Type 2 diabetes
|Title=A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese
|RiskAllele=T
|Pval=9E-10
|OR=1.57
|ORtxt=[1.36-1.82]
|OA=1
}}

{{PMID Auto
|PMID=21767287
|Title=Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort.
}}

{{PMID Auto
|PMID=23147557
|Title=PPAR-gamma2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.
}}

{{PMID Auto
|PMID=23462794
|Title=Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}